1 Min Read
NEW YORK, March 4 (Reuters) - Depomed Inc : * Resumes trading down 15.8 percent to $5.50 after FDA advisory committee rejects menopause drug
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.